Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin, Fenofibrate and Their Combination.
Phase of Trial: Phase II/III
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Fenofibrate; Metformin
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; Fournier Pharma
- 25 Feb 2008 Patient numbers amended from 100 to 8.
- 31 Aug 2007 Status change from in progress to discontinued.
- 21 Jul 2007 Status change from recruiting to in progress.